In a year when ECM bankers have been starved of big capital raises, Orora’s monster $1.35 billion equity raise (the biggest since Atlas Arteria) should have got everyone’s blood pumping, but it wasn’t to be. As Orora resumed trading on Wednesday, shares opened at $2.85 – above the $2.70 offer price but a fair way off the $3.16 theoretical ex-rights price (TERP). They recovered somewhat through the day, trading as high as $2.95 and closing at $2.88. That’s not exactly great. And neither was the 83 per cent institutional takeup for its non-renounceable rights issue. Even with the sword of dilution hanging above their heads, a big chunk of its investors chose to forgo the deal. |